comparemela.com

Latest Breaking News On - Fite biopharma - Page 5 : comparemela.com

Can-Fite BioPharma, Ltd. to Present at the LD Micro Invitational | The Kingston Whig Standard

Ramat Gan, Israel (Newsfile Corp. - April 1, 2024) - Can-Fite BioPharma, Ltd. (NYSE American: CANF) announced today that it will be

Motti-farbstein
Fite-biopharma-ltd
Fite-biopharma

Can-Fite BioPharma, Ltd. to Present at the LD Micro Invitational XIV

Can-Fite BioPharma, Ltd. announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024. The event is expected to feature 80.

United-states
American
Motti-farbstein
Drug-administration
Fite-biopharma-ltd
Israel-newsfile-corp
Ramat-gan
Fite-biopharma
Sofitel-new-york
Can-fite-biopharma
Orphan-drug-designation
Fast-track-designation

Can-Fite Reports 2023 Financial Results and Clinical Update

Ewopharma acquired marketing rights for namodenoson in the treatment of pancreatic carcinoma .

Ramat-gan
Tel-aviv
Israel
Canada
China
Japan
United-states
Canadian
American
Motti-farbstein
Company-annual-report-on-form
Drug-administration

Can-Fite BioPharma Ltd.: Can-Fite Reports 2023 Financial Results and Clinical Update

Can-Fite BioPharma Ltd.: Can-Fite Reports 2023 Financial Results and Clinical Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Israel
Ramat-gan
Tel-aviv
United-states
Japan
Canada
China
Canadian
American
Fite-biopharma
Motti-farbstein
Dennis-riedl

Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update

Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Canada
Ramat-gan
Tel-aviv
China
United-states
Japan
American
Canadian
Motti-farbstein
Fite-biopharma
Company-annual-report-on-form
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.